Benmelstobart Biosimilar - Research Grade

Human

PD-L1

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q9NZQ7

Blue ice

Programmed death-ligand 1 (PD-L1) engages PD-1 to suppress T-cell responses and is among the most intensively investigated checkpoint ligands in cancer research. This reagent is an unconjugated, non-therapeutic analog of benmelstobart, a human IgG1-kappa recombinant antibody for research use only. It is provided as an ultra-pure, low-endotoxin formulation meeting in vivo standards and produced in scalable milligram-to-gram quantities for high-throughput laboratories. It supports checkpoint functional assays, ligand-blockade and T-cell activation studies, ADCC characterization, in vitro screening and in vivo tumor models that examine PD-L1 signaling.

CD274ï؟½

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks